Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry.
BACKGROUND: Antidepressant (AD) use has been purported to increase the risk of breast and ovarian cancer, although both epidemiological and pre-clinical studies have reported mixed results. Previous studies in a variety of biomedical fields have found that financial ties to drug companies are associ...
Main Authors: | Lisa Cosgrove, Ling Shi, David E Creasey, Maria Anaya-McKivergan, Jessica A Myers, Krista F Huybrechts |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3071810?pdf=render |
Similar Items
-
Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.
by: Krista F Huybrechts, et al.
Published: (2014-01-01) -
A comparison of DSM-IV and DSM-5 panel members' financial associations with industry: a pernicious problem persists.
by: Lisa Cosgrove, et al.
Published: (2012-01-01) -
Drivers of and Solutions for the Overuse of Antidepressant Medication in Pediatric Populations
by: Lisa Cosgrove, et al.
Published: (2020-02-01) -
The antidepressant properties of ketamine (literature review)
by: F. Z. Chamsi, et al.
Published: (2023-03-01) -
Are antidepressants addictive? a literature review
by: M. Turki, et al.
Published: (2023-03-01)